Kennedy Capital Management »

Nurix Therapeutics shares owned by Kennedy Capital Management

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Kennedy Capital Management from 13F filings

Historical chart of Kennedy Capital Management investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Kennedy Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Kennedy Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.7M 161k 10.32
2023-09-30 $1.3M 164k 7.86
2023-06-30 $559k 56k 9.99

More positions owned by Kennedy Capital Management

Stifel Financial (SF)
Lithia Motors (LAD)
Home BancShares (HOMB)
Wintrust Financial Corporation (WTFC)
Crane Company (CR)
Casella Waste Systems (CWST)
Columbia Banking System (COLB)
South State Corporation (SSB)
Informatica (INFA)
Chart Industries (GTLS)
Assurant (AIZ)
Performance Food (PFGC)
Insight Enterprises (NSIT)
Ban (TBBK)
Installed Bldg Prods (IBP)

View all positions for Kennedy Capital Management

Top funds holding Nurix Therapeutics

Baker Bros. Advisors
Redmile Group
ARK Investment Management
Vanguard Group
T. Rowe Price Associates
Daniel D. Thurber
Dimensional Fund Advisors
Candriam Luxembourg S.C.A.
Charles Schwab Investment Management
Deutsche Bank Aktiengesellschaft
Millennium Management
Bessemer
Arrowpoint Asset Management
Taddei, Ludwig & Associates
Goldman Sachs Group

View all funds holding Nurix Therapeutics